Subscribe to Newsletter

Clinical Trials

Business & Regulation Business Practice

Tips for Development Success in a Troubling Economic Environment

Ali Pashazadeh from Treehill Partners offers his advice for navigating the turbulent period and keeping on track for commercial success.

Discovery & Development Clinical Trials

Clinical Trials: How Far We’ve Come

| Claude Price | 6 min read

Clinical trials have improved greatly over the years, but there is still much to be done.

Discovery & Development Clinical Trials

Body Positive

| Rob Coker | 2 min read

Almirall’s humanized monoclonal antibody treatment for psoriasis brings positivity for patients

Discovery & Development Clinical Trials

Ignaz Semmelweis, We Salute You

| Rob Coker | 4 min read

In the second episode of the We Salute You series, we focus on much maligned Hungarian physician Ignaz Semmelweis

Discovery & Development Clinical Trials

Clinical Trials: Decentralization and Digital Chaos

| Katrina Rice | 5 min read

Modern data strategies are needed as the landscape for clinical trials changes.

Discovery & Development Clinical Trials

Digitally Decentralized by Design

| Rob Coker | 3 min read

Through a partnership with software developer Medable, Syneos Health aims to decentralize and personalize clinical trials.

Discovery & Development Clinical Trials

The World’s Most Studied Disease

| Rob Coker | 5 min read

Breast cancer was the most researched disease in 2022. Phesi CEO Gen Li discusses what helps and what hinders the breast cancer research process.

Discovery & Development Clinical Trials

Putting Real-World Data to Work

| Karen Ooms | 4 min read

How do we further integrate real-world data into clinical research and approval processes?

Discovery & Development Drug Delivery

Connected Patient-Centricity

| Oliver Eden | 5 min read

How digital health technology can help clinical trials be more inclusive and accessible.

Discovery & Development Clinical Trials

Save One Person and You Heal the World

| Angus Stewart | 8 min read

An inside view on the French pharma company and Swiss NPO working on a treatment for a debilitating rare disease

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register